You are here

bevacizumab

Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock

Endpoints

Tue, 05/31/22 - 10:51 am

Outlook Therapeutics

wet age-related macular degeneration

Samsung Bioepis announces phase 3 results of SB8, Bevacizumab biosimilar candidate, at ESMO 2019 Congress

Pharmaceutical Business Review

Fri, 09/27/19 - 09:34 am

Samsung Bioepis

clinical trials

non-small cell lung cancer

Amgen Highlights Phase 2 Results Of Vectibix Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer

Yahoo/PR NewsWire

Sat, 05/31/14 - 10:07 am

colorectal cancer

Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma

Yahoo/MarketWire

Sun, 09/30/12 - 10:33 am

Threshold Pharmaceuticals